SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2017-05-24
Tx date 2017-05-17
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation)
Rossi, Tom
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+900,000 vol
8,048,325
Filed 2017-03-13
Tx date 2017-03-10
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation)
Rossi, Tom
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+2,000,000 vol
7,148,325
Filed 2016-08-23
Tx date 2016-08-23
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation)
Rossi, Tom
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+325,000 vol
5,148,325
Filed 2016-06-22
Tx date 2016-06-21
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation)
Rossi, Tom
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,080
+16,000 vol
$0.13 each
291,000
Filed 2016-06-22
Tx date 2016-06-21
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation)
Rossi, Tom
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$12,900
+100,000 vol
$0.129 each
275,000
Filed 2016-03-08
Tx date 2016-03-04
$ASP
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation)
Rossi, Tom
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+2,000,000 vol
4,823,325
Filed 2015-09-08
Tx date 2015-09-08
$TRL
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation)
Rossi, Tom
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,860
+4,000 vol
$0.465 each
172,000
Filed 2015-09-08
Tx date 2015-09-08
$TRL
Acerus Pharmaceuticals Corporation (formerly Trimel Pharmaceuticals Corporation)
Rossi, Tom
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,335
+3,000 vol
$0.445 each
175,000
Filed 2015-09-04
Tx date 2015-09-03
$TRL
Trimel Pharmaceuticals Corporation (formerly J5 Acquisition Corp.)
Rossi, Tom
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$7,990
+17,000 vol
$0.47 each
168,000
Filed 2015-08-27
Tx date 2015-08-27
$TRL
Trimel Pharmaceuticals Corporation (formerly J5 Acquisition Corp.)
Rossi, Tom
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,700
+6,000 vol
$0.45 each
151,000
Filed 2015-08-27
Tx date 2015-08-27
$TRL
Trimel Pharmaceuticals Corporation (formerly J5 Acquisition Corp.)
Rossi, Tom
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,185
+7,000 vol
$0.455 each
145,000
Filed 2015-08-21
Tx date 2015-08-20
$TRL
Trimel Pharmaceuticals Corporation (formerly J5 Acquisition Corp.)
Rossi, Tom
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$574.50
+1,500 vol
$0.383 each
138,000
Filed 2015-08-20
Tx date 2015-08-19
$TRL
Trimel Pharmaceuticals Corporation (formerly J5 Acquisition Corp.)
Rossi, Tom
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,172
+5,500 vol
$0.395 each
130,500
Filed 2015-08-20
Tx date 2015-08-19
$TRL
Trimel Pharmaceuticals Corporation (formerly J5 Acquisition Corp.)
Rossi, Tom
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,364
+6,000 vol
$0.394 each
136,500
Filed 2015-08-07
Tx date 2015-08-07
$TRL
Trimel Pharmaceuticals Corporation (formerly J5 Acquisition Corp.)
Rossi, Tom
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$20,250
+45,000 vol
$0.45 each
125,000